Reporting Segment Product Line Amount (USD)arrow_drop_up Percentage
keyboard_arrow_right Reporting Segment & Product Line Amount (USD) Percentage
Injectable Pharmaceuticals
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
3.81M 1.20%
Injectable Pharmaceuticals
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
98.27M 31.04%
Injectable Pharmaceuticals
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
214.54M 67.76%
keyboard_arrow_right keyboard_arrow_down
Injectable Pharmaceuticals
Pre-Revenue Pharmaceuticals
3.81M 1.20%
keyboard_arrow_right
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
keyboard_arrow_right keyboard_arrow_down
Injectable Pharmaceuticals
Pharmaceutical Patent Licensing
98.27M 31.04%
keyboard_arrow_right
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
keyboard_arrow_right keyboard_arrow_down
Injectable Pharmaceuticals
Branded Pharmaceuticals (outsourced)
214.54M 67.76%
keyboard_arrow_right
These companies research, develop, and outsource the manufacturing of patented drugs.